ISPC · iSpecimen Inc. · Metrics
$1.59
+0.00 (+0.00%)
At close · Sep 9
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt regarding the Company's ability to continue as a going concern for a period of one year from the date these unaudited condensed financial statements are issued. Management's plan to mitigate the conditions that raise substantial doubt includes generating additional revenues, deferring certain projects and capital expenditures and eliminating certain future operating expenses for the Company to continue as a going concern. However, there can be no assurance that the Company will be successful in completing any of these options. As a result, management's plans cannot be considered probable and thus do not alleviate substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$3.88M
Shares
2.52M
ISPC metrics
49 of 115 screener metrics currently available.
Market overview
2 metricsShare price
$1.59
Market cap
$3.88M
Price action
20 metricsPrice change (1W)
+0.0%
Price change (30D)
-31.3%
Price change (3M)
-49.0%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
99.6%
Annualized volatility (3M)
93.4%
Beta
—
RSI (14D)
34.2
Price vs SMA 50
-27.2%
Price vs SMA 200
—
Avg volume (3M)
335,922
Relative volume
19.6
Average dollar volume
$672,183
Company
3 metricsSector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
2.52M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
8.3×
reciprocal yield 12.0%
P / book
2.2
reciprocal yield 44.8%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-294.4%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
-0.4×
EV / revenue historical average (5Y)
-0.4×
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2024-08-06
Profitability
9 metricsGross margin
-67.2%
Operating margin
-2,020.0%
Trailing 12 months
Net margin
-2,449.0%
Gross profit (TTM)
—
Operating profit (TTM)
−$9.42M
Net income (TTM)
−$11.42M
Trailing 12 months
Diluted EPS (TTM)
$-53.51
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-78.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$466,302
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+2,133.9%
Year over year · more shares
Revenue CAGR (3Y)
-43.0%
Revenue CAGR (5Y)
-25.1%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-657.7%
Return on assets
-154.5%
Debt / equity
—
Current ratio
0.8
EBITDA (TTM)
−$8.22M
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$4.41M
Total assets
$7.39M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$7.00M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$4,743
R&D / revenue
—
Stock compensation / revenue
1.0%
Ownership (13F)
3 metrics13F filers
8
13F filer change QoQ
-4
Institutional ownership
2.6%
Short interest
3 metricsShort interest
5.9%
Latest settlement · 1.9 days to cover
Days to cover
1.9d
Short-squeeze score
64 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
Flagged